Iris C M Pelsma
Overview
Explore the profile of Iris C M Pelsma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
109
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Golub D, White T, Shah H, Khaleghi M, Huntoon K, Zandbergen I, et al.
Pituitary
. 2025 Feb;
28(1):28.
PMID: 39900842
Background: Prolactinomas represent the most common pituitary adenoma subtype, the majority of which are microprolactinomas. Dopamine agonists (DAs) remain the first-line intervention for microprolactinomas, however, many patients either cannot tolerate...
2.
Pelsma I, Kroon H, Andela C, van der Linden E, Kloppenburg M, Biermasz N, et al.
Pituitary
. 2024 Nov;
27(6):824-836.
PMID: 39485592
Following the description of an illustrative case of a 70-year-old female patient with longstanding active acromegaly and invalidating, progressive joint complaints, current insights regarding diagnosis, treatment, and long-term management of...
3.
van Trigt V, Bakker L, Pelsma I, Zandbergen I, Jentus M, Kruit M, et al.
J Clin Endocrinol Metab
. 2024 Sep;
PMID: 39292628
Purpose: To evaluate patients with prolactinoma treated surgically in a time when elective prolactinoma surgery became routine in our center, using a comprehensive outcome set, focusing on preoperative assessments, surgical...
4.
van Trigt V, Bakker L, Lu H, Pelsma I, Verstegen M, van Furth W, et al.
Pituitary
. 2024 Jul;
27(5):614-624.
PMID: 39042164
Purpose: To assess the utility of [F]fluoroethyl-L-tyrosine PET co-registered with magnetic resonance imaging ([F]FET-PET/MRI) in patients with difficult-to-localize prolactinoma to inform clinical decision-making and (surgical) treatment planning. Methods: Retrospective cohort...
5.
Bakker L, Verstegen M, Manole D, Lu H, Decramer T, Pelsma I, et al.
Clin Endocrinol (Oxf)
. 2024 May;
101(2):142-152.
PMID: 38818709
Objective: To report our experience with F-fluoro-ethyl-tyrosine (FET) positron emission tomography-computed tomography (PET-CT) co-registered with magnetic resonance imaging (MRI) (FET-PET/MRI) in the care trajectory for persistent acromegaly. Design: Prospective case...
6.
van Trigt V, Zandbergen I, Pelsma I, Bakker L, Verstegen M, van Furth W, et al.
Pituitary
. 2023 Oct;
26(6):725-728.
PMID: 37897644
No abstract available.
7.
Pelsma I, Fassnacht M, Tsagarakis S, Terzolo M, Tabarin A, Sahdev A, et al.
Eur J Endocrinol
. 2023 Oct;
189(4):S88-S101.
PMID: 37801655
Objective: To assess (1) comorbidities associated with and (2) treatment strategies for patients with adrenal incidentalomas and mild autonomous cortisol secretion (MACS; > 1.8 µg/dL (>50 nmol/L) cortisol level cut-off...
8.
van Trigt V, Zandbergen I, Pelsma I, Bakker L, Verstegen M, van Furth W, et al.
Pituitary
. 2023 Sep;
26(5):611-621.
PMID: 37690076
Purpose: To describe care trajectories in patients with prolactinoma, aiming to clarify the rationale for surgery. Methods: Retrospective observational cohort study of consecutive patients with prolactinoma undergoing surgery from 2017...
9.
Lu L, Pelsma I, de Vries F, van Hulst-Ginjaar S, van Furth W, Verstegen M, et al.
J Neuroophthalmol
. 2023 Sep;
44(3):406-413.
PMID: 37669254
Background: This retrospective, observational cohort study aimed to determine recovery rate and recovery time of ocular motor nerve palsies (OMP) of third (CN III), fourth (CN IV), or sixth cranial...
10.
van Trigt V, Pelsma I, Biermasz N
Pituitary
. 2023 Apr;
26(3):307-317.
PMID: 37014498
Purpose: To describe quality and outcomes of patient-reported outcome (PRO) measures (PROMs) used in patients with refractory hormone-producing pituitary adenomas, and to provide an overview of PROs in these challenging...